Abstract . Many questions have been answered, and many more generated, from the last few years. For example, is COVID-19 acute respiratory failure and acute respiratory distress syndrome similar to non-COVID-19? How can we personalize therapy in patients

Abstract benefit; however, current clinical trials/evidence are at a very early stage. This review will provide a broad overview of the role of NETs and their possible treatment in respiratory disease.Copyright © 2024 by the authors.

Abstract to NIV (RR 0.70, 95% CI 0.50 to 0.98; p=0.04; 16 studies, n=3076). In subgroup analyses, when considering patients by illness types, those with acute-on-chronic respiratory failure who received HFNO compared with COT had a significant reduction in

Abstract about each admission. Result(s): Preliminary analysis identified 353 Respiratory patient admissions treated by HITH over a 5-year period from 2015 to 2020. In the preliminary analysis performed so far, all the HITH admissions utilized intravenous